The landscape of diabetic management is rapidly evolving, and cellular treatment are emerging as a especially innovative area of study. While existing treatments often focus on managing blood glucose levels and addressing related problems, cell-based intervention holds the potential to target the underlying causes of Type 2 diabetic conditions. Sci